AbCellera shareholders elect Hansen and Hayden as Class II directors at annual meeting

AbCellera Biologics Inc.

Carl G. Hansen re-elected with 140.1M for, 32.2M against; Michael Hayden elected with 147.0M for, 25.3M against.
KPMG ratified as independent auditor for FY 2022: 202.0M for, 0.4M against, 10.7M abstain.
Non-binding say-on-pay approved: 167.8M for, 4.4M against, 10.7M abstain.
Advisory vote favored one-year frequency for future say-on-pay: 171.7M for one year.
Total outstanding shares: 284.5M; broker non-votes of 30.2M on director and say-on-pay proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.